• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cells . The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19

tetano

Editor, Senior Moderator
Cells


. 2022 Oct 28;11(21):3411.
doi: 10.3390/cells11213411.
The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19


Helena T Hogberg[SUP] 1 2 [/SUP], Ann Lam[SUP] 3 4 [/SUP], Elan Ohayon[SUP] 3 5 [/SUP], Muhammad Ali Shahbaz[SUP] 6 [/SUP], Laure-Alix Clerbaux[SUP] 7 [/SUP], Anna Bal-Price[SUP] 7 [/SUP], Sandra Coecke[SUP] 7 [/SUP], Rachel Concha[SUP] 3 [/SUP], Francesca De Bernardi[SUP] 8 [/SUP], Eizleayne Edrosa[SUP] 3 [/SUP], Alan J Hargreaves[SUP] 9 [/SUP], Katja M Kanninen[SUP] 6 [/SUP], Amalia Munoz[SUP] 10 [/SUP], Francesca Pistollato[SUP] 7 [/SUP], Surat Saravanan[SUP] 11 [/SUP], Natàlia Garcia-Reyero[SUP] 12 [/SUP], Clemens Wittwehr[SUP] 7 [/SUP], Magdalini Sachana[SUP] 13 [/SUP]



Affiliations

Abstract

Several reports have shown that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has the potential to also be neurotropic. However, the mechanisms by which SARS-CoV-2 induces neurologic injury, including neurological and/or psychological symptoms, remain unclear. In this review, the available knowledge on the neurobiological mechanisms underlying COVID-19 was organized using the AOP framework. Four AOPs leading to neurological adverse outcomes (AO), anosmia, encephalitis, stroke, and seizure, were developed. Biological key events (KEs) identified to induce these AOs included binding to ACE2, blood-brain barrier (BBB) disruption, hypoxia, neuroinflammation, and oxidative stress. The modularity of AOPs allows the construction of AOP networks to visualize core pathways and recognize neuroinflammation and BBB disruption as shared mechanisms. Furthermore, the impact on the neurological AOPs of COVID-19 by modulating and multiscale factors such as age, psychological stress, nutrition, poverty, and food insecurity was discussed. Organizing the existing knowledge along an AOP framework can represent a valuable tool to understand disease mechanisms and identify data gaps and potentially contribute to treatment, and prevention. This AOP-aligned approach also facilitates synergy between experts from different backgrounds, while the fast-evolving and disruptive nature of COVID-19 emphasizes the need for interdisciplinarity and cross-community research.

Keywords: AOP; SARS-CoV-2; anosmia; encephalitis; human-specific research; neuropathology; stroke.
 
Back
Top Bottom